Epigral Ltd.

EPIGRAL

₹1913.2

1.25% (23.7)

Market Cap

₹8,256 Cr.

P/E

23.72

About

Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The company is also engaged in trading of Agroche… Read more

Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufact… Read more

Low

1110

52W Range

High

2407

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
Sales Growth

Unable to calculate due to limited data

Market Share

0 %

(as of Mar 22)

Source/Historic

Chlor-Alkalis - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

Manufacturing Capacity - Caustic Soda (MTPA)
Source
Realization / Tonne - Caustic Soda (Rs/MT)
Source
Manufacturing Capacity - Caustic Potash (MTPA)
Source
Capacity Utilization - Chemicals (%)
Source
Capacity Utilization - Chlor-Alkali (%)
Source
Manufacturing Capacity - Chloromethanes (MTPA)
Source
Manufacturing Capacity - Hydrogen Peroxide (MTPA)
Source
Manufacturing Capacity - CPVC Resin (MTPA)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Epigral Ltd. Business

What does Epigral do?

Epigral Limited, formerly known as Meghmani Finechem Limited, is a leading ISO-certified company manufacturing and selling Chlor Alkali & its Derivatives with backward and forward integration facilities.

Who are the competitors of Epigral?

Epigral major competitors are DCM Shriram, Guj. Alkalies & Chem, Chemfab Alkalis, TGV SRACC, Primo Chemicals, TN Petro Products, Lords Chloro Alkali.
Market Cap of Epigral is ₹8,155 Crs.
While the median market cap of its peers are ₹1,074 Crs.

Is Epigral financially stable compared to its competitors?

Epigral seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Apr Jun Jul Aug Sep Dec	Jan Mar Jun Sep Dec	Jun Sep Dec	Mar Dec	Mar Jun Sep Dec	Mar Sep Dec	Mar Jun Sep Dec	Jun
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec		Mar Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Epigral Ltd.

From Commodity to Specialty Chemicals - Meghmani Finechem - Logical Investor

Corporate Governance Red Flags At Meghmani - Logical Investor

Value Chain - Meghmani Finechem - Dr Prashanth Mishra

Epigral Ltd: How this chemical company is replacing Chinese Imports - Green Portfolio

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Epigral Ltd.